300676.SZ
华大基因
SZSE · Healthcare · M 科研服务 · CN
CNY 41.90
−0.71%Margins
Gross margin
37.0%
EBITDA margin
-1.5%
EBIT margin
-14.0%
Net margin
-14.9%
FCF margin
-9.3%
-6.8%
Return on equity
-5.1%
Return on assets
-6.0%
Return on invested capital
0.33x
Asset turnover
CNY 152.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026